Notice of Closed Meeting, 60427-60428 [2018-25589]

Download as PDF Federal Register / Vol. 83, No. 227 / Monday, November 26, 2018 / Notices STATUS: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: indirectly acquire voting shares of, Lubbock National Bank, both of Lubbock, Texas. Closed Session 1. Fact Finding No. 28—Final Report—Briefing by Commissioner Rebecca F. Dye. Board of Governors of the Federal Reserve System, November 20, 2018. Yao-Chin Chao, Assistant Secretary of the Board. CONTACT PERSON FOR MORE INFORMATION: Rachel Dickon, Secretary, (202) 523– 5725. Rachel Dickon, Secretary. [FR Doc. 2018–25814 Filed 11–21–18; 4:15 pm] BILLING CODE 6731–AA–P FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than December 20, 2018. A. Federal Reserve Bank of Dallas (Robert L. Triplett III, Senior Vice President) 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. Amarillo National Bancorp, Inc., Amarillo, Texas; to acquire 100 percent of the voting shares of Commerce National Financial Services, Inc., and VerDate Sep<11>2014 17:28 Nov 23, 2018 Jkt 247001 [FR Doc. 2018–25674 Filed 11–23–18; 8:45 am] 60427 Board of Governors of the Federal Reserve System, November 20, 2018. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2018–25676 Filed 11–23–18; 8:45 am] BILLING CODE P BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES FEDERAL RESERVE SYSTEM Centers for Disease Control and Prevention Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as The notificants listed below have amended, notice is hereby given of the applied under the Change in Bank following meeting. Control Act (12 U.S.C. 1817(j)) and The meeting will be closed to the § 225.41 of the Board’s Regulation Y (12 public in accordance with the CFR 225.41) to acquire shares of a bank provisions set forth in sections or bank holding company. The factors 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., that are considered in acting on the as amended, and the Determination of notices are set forth in paragraph 7 of the Chief Operating Officer, CDC, the Act (12 U.S.C. 1817(j)(7)). pursuant to Public Law 92–463. The The notices are available for grant applications and the discussions immediate inspection at the Federal could disclose confidential trade secrets Reserve Bank indicated. The notices or commercial property such as also will be available for inspection at patentable material, and personal the offices of the Board of Governors. information concerning individuals Interested persons may express their associated with the grant applications, views in writing to the Reserve Bank the disclosure of which would indicated for that notice or to the offices constitute a clearly unwarranted of the Board of Governors. Comments invasion of personal privacy. must be received not later than Name of Committee: Disease, December 10, 2018. Disability, and Injury Prevention and A. Federal Reserve Bank of Cleveland Control Special Emphasis Panel (SEP)– (Nadine Wallman, Vice President) 1455 RFA–IP–19–001, Surveillance for East Sixth Street, Cleveland, Ohio Respiratory Syncytial Virus (RSV) and 44101–2566. Comments can also be sent Other Viral Respiratory Infections electronically to Among Native Americans/Alaskan Comments.applications@clev.frb.org: Natives; RFA–IP–19–002, Increasing 1. The Richard F. McCready, Jr. Influenza and Tdap Vaccination of Maximum United Credit Trust, Jane Pregnant Women in Obstetric/ Houston McCready, Trustee, Gynecologic Practices in Large Health Winchester, Kentucky, Sarah McCready Systems through Quality Improvement Boston, Trustee and Louise F. McCready Interventions; and RFA–IP–19–003, Hart, Trustee, both of New York, New Understanding and Improving York; to join the McCready family Immunization Services Among Adult group, a group acting in concert, to Hospital Inpatient and Observation/ acquire shares of WinFirst Financial Clinical Decision Unit Settings. Corporation, Winchester, Kentucky, and Date: March 19–20, 2019. thereby acquire shares of Winchester Time: 10:00 a.m.–5:00 p.m., (EST). Federal Bank, Winchester, Kentucky. Place: Teleconference, Centers for B. Federal Reserve Bank of Dallas Disease Control and Prevention, Room (Robert L. Triplett III, Senior Vice 1080, 8 Corporate Square Blvd., Atlanta, President) 2200 North Pearl Street, GA 30329. Dallas, Texas 75201–2272: Agenda: To review and evaluate grant 1. Arthur Haag Sherman, the applications. Sherman 2018 Irrevocable Trust, For Further Information Contact: Sherman Tectonic FLP LP, and Sherman Gregory Anderson, M.S., M.P.H., Family Holdings LLC, all of Houston, Scientific Review Officer, CDC, 1600 Texas; as a group acting in concert, to Clifton Road, NE, Mailstop E60, Atlanta, acquire shares of T Acquisition, Inc., Georgia 30329, (404) 718–8833, gca5@ and thereby indirectly acquire T Bank, cdc.gov. National Association, both of Dallas, The Chief Operating Officer, Centers Texas. for Disease Control and Prevention, has PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\26NON1.SGM 26NON1 60428 Federal Register / Vol. 83, No. 227 / Monday, November 26, 2018 / Notices been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–25589 Filed 11–23–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10286, CMS– 10440 and CMS–10507] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by January 25, 2019. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the SUMMARY: VerDate Sep<11>2014 17:28 Nov 23, 2018 Jkt 247001 instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number__, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. 2. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 3. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786–1326. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10286 Notice of Research Exception under the Genetic Information Nondiscrimination Act CMS–10440 Data Collection to Support Eligibility Determinations for Insurance Affordability Programs and Enrollment through Affordable Insurance Exchanges, Medicaid and Children’s Health Insurance Program Agencies (CMS–10440) CMS–10507 State-based Exchange Annual Report Tool (SMART) Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Notice of Research Exception under the Genetic Information Nondiscrimination Act; Use: Under the Genetic Information Nondiscrimination Act of 2008 (GINA), a plan or issuer may request (but not require) a genetic test in connection with certain research activities so long as such activities comply with specific requirements, including: (i) The research complies with 45 CFR part 46 or equivalent federal regulations and applicable State or local law or regulations for the protection of human subjects in research; (ii) the request for the participant or beneficiary (or in the case of a minor child, the legal guardian of such beneficiary) is made in writing and clearly indicates that compliance with the request is voluntary and that non-compliance will have no effect on eligibility for benefits or premium or contribution amounts; and (iii) no genetic information collected or acquired will be used for underwriting purposes. The Secretary of Labor or the Secretary of Health and Human Services is required to be notified if a group health plan or health insurance issuer intends to claim the research exception permitted under Title I of GINA. Nonfederal governmental group health plans and issuers solely in the individual health insurance market or Medigap market will be required to file with the Centers for Medicare & Medicaid Services (CMS). The Notice of Research Exception under the Genetic Information Nondiscrimination Act is a model notice that can be completed by group health plans and health insurance issuers and filed with either the Department of Labor or CMS to comply with the notification requirement. Form Number: CMS–10286 (OMB control number 0938–1077); Frequency: Occasionally; Affected Public: State, Local or Tribal Governments; Private Sector; Number of Respondents: 2; Number of Responses: 2; Total Annual Hours: 0.5. (For policy questions regarding this collection contact Usree Bandyopadhyay at 410–786–6650.) 2. Type of Information Collection Request: Extension of a currently approved collection; Title of E:\FR\FM\26NON1.SGM 26NON1

Agencies

[Federal Register Volume 83, Number 227 (Monday, November 26, 2018)]
[Notices]
[Pages 60427-60428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25589]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)-RFA-IP-19-001, Surveillance for 
Respiratory Syncytial Virus (RSV) and Other Viral Respiratory 
Infections Among Native Americans/Alaskan Natives; RFA-IP-19-002, 
Increasing Influenza and Tdap Vaccination of Pregnant Women in 
Obstetric/Gynecologic Practices in Large Health Systems through Quality 
Improvement Interventions; and RFA-IP-19-003, Understanding and 
Improving Immunization Services Among Adult Hospital Inpatient and 
Observation/Clinical Decision Unit Settings.
    Date: March 19-20, 2019.
    Time: 10:00 a.m.-5:00 p.m., (EST).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road, NE, Mailstop E60, 
Atlanta, Georgia 30329, (404) 718-8833, [email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has

[[Page 60428]]

been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-25589 Filed 11-23-18; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.